2025 Retina Update, Part 1: Injectables in the Medical Retina Space

Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies, private equity acquisitions, and the new drug pipeline. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Om Podcasten

Practical, topical conversations with experts across the spectrum of ophthalmology. Subscribe for the latest information, evidence-based practice standards, and innovations in eye care, from the American Academy of Ophthalmology.